Invention Grant
- Patent Title: Substituted pyridine derivatives useful as GSK-3 inhibitors
-
Application No.: US15033770Application Date: 2014-11-03
-
Publication No.: US09809573B2Publication Date: 2017-11-07
- Inventor: Guanglin Luo , Ling Chen , Gene M. Dubowchik , Swanee E. Jacutin-Porte , Prasanna Sivaprakasam , John E. Macor
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent James Epperson
- International Application: PCT/US2014/063666 WO 20141103
- International Announcement: WO2015/069593 WO 20150514
- Main IPC: C07D401/12
- IPC: C07D401/12 ; C07D401/14 ; C07D405/14 ; C07D409/14 ; C07D413/14 ; C07D417/12 ; C07D417/14 ; C07D487/08 ; C07D513/04 ; C07D213/81 ; C07D401/04 ; C07D405/04 ; C07D409/04 ; C07D413/04 ; C07D417/04
Abstract:
The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds are ligands, antagonists of the NR2B receptor and may be useful for the treatment of various disorders of the central nervous system.
Public/Granted literature
- US20160289210A1 Substituted Pyridine Derivatives Useful as GSK-3 Inhibitors Public/Granted day:2016-10-06
Information query
